Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021

Upgrades

For Callaway Golf Co ELY, Compass Point upgraded the previous rating of Neutral to Buy. Callaway Golf earned $0.36 in the second quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $37.75 and a 52-week-low of $14.62. At the end of the last trading period, Callaway Golf closed at $26.60.

Cowen & Co. upgraded the previous rating for Airbnb Inc ABNB from Market Perform to Outperform. For the second quarter, Airbnb had an EPS of $0.11, compared to year-ago quarter EPS of $1.30. The stock has a 52-week-high of $219.94 and a 52-week-low of $121.50. At the end of the last trading period, Airbnb closed at $166.67.

For Protagonist Therapeutics Inc PTGX, JP Morgan upgraded the previous rating of Neutral to Overweight. Protagonist Therapeutics earned $0.69 in the second quarter, compared to $0.59 in the year-ago quarter. At the moment, the stock has a 52-week-high of $50.54 and a 52-week-low of $12.80. Protagonist Therapeutics closed at $35.36 at the end of the last trading period.

For Square Inc SQ, Atlantic Equities upgraded the previous rating of Neutral to Overweight. For the second quarter, Square had an EPS of $0.66, compared to year-ago quarter EPS of $0.18. At the moment, the stock has a 52-week-high of $289.23 and a 52-week-low of $151.10. Square closed at $232.33 at the end of the last trading period.

For Kirby Corp KEX, Stifel upgraded the previous rating of Hold to Buy. For the second quarter, Kirby had an EPS of $0.17, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $70.60 and a 52-week-low of $35.76. At the end of the last trading period, Kirby closed at $52.63.

For Gold Fields Ltd GFI, RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the fourth quarter, Gold Fields had an EPS of $0.02, compared to year-ago quarter EPS of $0.02. At the moment, the stock has a 52-week-high of $13.21 and a 52-week-low of $7.75. Gold Fields closed at $8.77 at the end of the last trading period.

According to UBS, the prior rating for Acuity Brands Inc AYI was changed from Sell to Neutral. Acuity Brands earned $3.27 in the fourth quarter, compared to $2.35 in the year-ago quarter. The stock has a 52-week-high of $209.42 and a 52-week-low of $87.90. At the end of the last trading period, Acuity Brands closed at $205.82.

Deutsche Bank upgraded the previous rating for Kilroy Realty Corp KRC from Sell to Hold. In the second quarter, Kilroy Realty showed an EPS of $0.88, compared to $0.78 from the year-ago quarter. At the moment, the stock has a 52-week-high of $74.05 and a 52-week-low of $45.28. Kilroy Realty closed at $68.11 at the end of the last trading period.

Evercore ISI Group upgraded the previous rating for Autoliv Inc ALV from In-Line to Outperform. Autoliv earned $1.20 in the second quarter, compared to $1.40 in the year-ago quarter. The stock has a 52-week-high of $108.76 and a 52-week-low of $74.53. At the end of the last trading period, Autoliv closed at $92.56.

Evercore ISI Group upgraded the previous rating for Lear Corp LEA from In-Line to Outperform. Lear earned $2.45 in the second quarter, compared to $4.14 in the year-ago quarter. The stock has a 52-week-high of $204.91 and a 52-week-low of $119.29. At the end of the last trading period, Lear closed at $167.76.

Credit Suisse upgraded the previous rating for MGM Resorts International MGM from Neutral to Outperform. In the second quarter, MGM Resorts Intl showed an EPS of $0.13, compared to $1.52 from the year-ago quarter. The current stock performance of MGM Resorts Intl shows a 52-week-high of $46.06 and a 52-week-low of $19.55. Moreover, at the end of the last trading period, the closing price was at $44.42.

See all analyst ratings upgrades.

Downgrades

For Archer-Daniels Midland Co ADM, Stephens & Co. downgraded the previous rating of Overweight to Equal-Weight. In the second quarter, Archer-Daniels Midland showed an EPS of $1.33, compared to $0.85 from the year-ago quarter. The stock has a 52-week-high of $69.30 and a 52-week-low of $45.68. At the end of the last trading period, Archer-Daniels Midland closed at $63.97.

For Charter Communications Inc CHTR, Deutsche Bank downgraded the previous rating of Buy to Hold. In the second quarter, Charter Communications showed an EPS of $5.29, compared to $3.63 from the year-ago quarter. At the moment, the stock has a 52-week-high of $825.62 and a 52-week-low of $572.46. Charter Communications closed at $695.23 at the end of the last trading period.

According to William Blair, the prior rating for Citrix Systems Inc CTXS was changed from Outperform to Market Perform. For the second quarter, Citrix Systems had an EPS of $1.24, compared to year-ago quarter EPS of $1.53. At the moment, the stock has a 52-week-high of $146.94 and a 52-week-low of $94.40. Citrix Systems closed at $94.68 at the end of the last trading period.

According to BMO Capital, the prior rating for Flexion Therapeutics Inc FLXN was changed from Outperform to Market Perform. In the second quarter, Flexion Therapeutics showed an EPS of $0.44, compared to $0.76 from the year-ago quarter. The current stock performance of Flexion Therapeutics shows a 52-week-high of $13.66 and a 52-week-low of $4.30. Moreover, at the end of the last trading period, the closing price was at $9.17.

According to JMP Securities, the prior rating for Adamas Pharmaceuticals Inc ADMS was changed from Market Outperform to Market Perform. For the second quarter, Adamas Pharmaceuticals had an EPS of $0.27, compared to year-ago quarter EPS of $0.37. The stock has a 52-week-high of $9.15 and a 52-week-low of $2.96. At the end of the last trading period, Adamas Pharmaceuticals closed at $8.07.

Piper Sandler downgraded the previous rating for First Bancorp FBNC from Overweight to Neutral. In the second quarter, First Bancorp showed an EPS of $1.04, compared to $0.56 from the year-ago quarter. The stock has a 52-week-high of $49.98 and a 52-week-low of $21.77. At the end of the last trading period, First Bancorp closed at $49.75.

For Trex Co Inc TREX, Baird downgraded the previous rating of Outperform to Neutral. Trex Co earned $0.53 in the second quarter, compared to $0.81 in the year-ago quarter. At the moment, the stock has a 52-week-high of $114.61 and a 52-week-low of $64.26. Trex Co closed at $103.04 at the end of the last trading period.

For Adamas Pharmaceuticals Inc ADMS, Piper Sandler downgraded the previous rating of Overweight to Neutral. Adamas Pharmaceuticals earned $0.27 in the second quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $9.15 and a 52-week-low of $2.96. Adamas Pharmaceuticals closed at $8.07 at the end of the last trading period.

For Adamas Pharmaceuticals Inc ADMS, HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. In the second quarter, Adamas Pharmaceuticals showed an EPS of $0.27, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $9.15 and a 52-week-low of $2.96. Adamas Pharmaceuticals closed at $8.07 at the end of the last trading period.

For Lumentum Holdings Inc LITE, Raymond James downgraded the previous rating of Strong Buy to Outperform. For the fourth quarter, Lumentum Holdings had an EPS of $1.15, compared to year-ago quarter EPS of $1.18. The stock has a 52-week-high of $112.08 and a 52-week-low of $65.67. At the end of the last trading period, Lumentum Holdings closed at $85.54.

Raymond James downgraded the previous rating for Flexion Therapeutics Inc FLXN from Strong Buy to Market Perform. Flexion Therapeutics earned $0.44 in the second quarter, compared to $0.76 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.66 and a 52-week-low of $4.30. Flexion Therapeutics closed at $9.17 at the end of the last trading period.

Credit Suisse downgraded the previous rating for Flexion Therapeutics Inc FLXN from Outperform to Neutral. For the second quarter, Flexion Therapeutics had an EPS of $0.44, compared to year-ago quarter EPS of $0.76. At the moment, the stock has a 52-week-high of $13.66 and a 52-week-low of $4.30. Flexion Therapeutics closed at $9.17 at the end of the last trading period.

According to Credit Suisse, the prior rating for Amkor Technology Inc AMKR was changed from Outperform to Neutral. In the second quarter, Amkor Technology showed an EPS of $0.51, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $29.50 and a 52-week-low of $10.83. Amkor Technology closed at $25.10 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

Roth Capital initiated coverage on Penn National Gaming Inc PENN with a Buy rating. The price target for Penn National Gaming is set to $107.00. Penn National Gaming earned $1.17 in the second quarter, compared to $1.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of $142.00 and a 52-week-low of $52.09. Penn National Gaming closed at $72.14 at the end of the last trading period.

With a Sell rating, Roth Capital initiated coverage on DraftKings Inc DKNG. The price target seems to have been set at $41.00 for DraftKings. For the second quarter, DraftKings had an EPS of $0.76, compared to year-ago quarter EPS of $0.55. The current stock performance of DraftKings shows a 52-week-high of $74.38 and a 52-week-low of $34.90. Moreover, at the end of the last trading period, the closing price was at $48.88.

Craig-Hallum initiated coverage on Lantronix Inc LTRX with a Buy rating. The price target for Lantronix is set to $11.00. In the fourth quarter, Lantronix showed an EPS of $0.06, compared to $0.04 from the year-ago quarter. The current stock performance of Lantronix shows a 52-week-high of $6.89 and a 52-week-low of $4.06. Moreover, at the end of the last trading period, the closing price was at $6.02.

Scotiabank initiated coverage on The Lion Electric Co LEV with a Sector Perform rating. The price target for Lion Electric is set to $16.50. In the second quarter, Lion Electric showed an EPS of $0.07, compared to $0.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.45 and a 52-week-low of $10.48. Lion Electric closed at $10.80 at the end of the last trading period.

With a Buy rating, Goldman Sachs initiated coverage on Nike Inc NKE. The price target seems to have been set at $172.00 for Nike. For the first quarter, Nike had an EPS of $1.16, compared to year-ago quarter EPS of $0.95. At the moment, the stock has a 52-week-high of $174.38 and a 52-week-low of $118.80. Nike closed at $150.28 at the end of the last trading period.

Evercore ISI Group initiated coverage on Viridian Therapeutics Inc VRDN with an Outperform rating. The price target for Viridian Therapeutics is set to $40.00. Viridian Therapeutics earned $2.21 in the second quarter, compared to $1.82 in the year-ago quarter. The stock has a 52-week-high of $25.19 and a 52-week-low of $10.44. At the end of the last trading period, Viridian Therapeutics closed at $15.65.

William Blair initiated coverage on Recro Pharma Inc REPH with an Outperform rating. In the second quarter, Recro Pharma showed an EPS of $0.03, compared to $0.25 from the year-ago quarter. The stock has a 52-week-high of $5.29 and a 52-week-low of $1.49. At the end of the last trading period, Recro Pharma closed at $1.86.

Citigroup initiated coverage on Enact Holdings Inc ACT with a Buy rating. The price target for Enact Holdings is set to $24.00. In the first quarter, Enact Holdings showed an EPS of $4.30, compared to $3.49 from the year-ago quarter. The current stock performance of Enact Holdings shows a 52-week-high of $28.16 and a 52-week-low of $19.25. Moreover, at the end of the last trading period, the closing price was at $20.45.

Piper Sandler initiated coverage on Ellington Residential Mortgage REIT EARN with an Overweight rating. The price target for Ellington Residential is set to $12.50. For the second quarter, Ellington Residential had an EPS of $0.37, compared to year-ago quarter EPS of $0.26. The current stock performance of Ellington Residential shows a 52-week-high of $13.92 and a 52-week-low of $10.56. Moreover, at the end of the last trading period, the closing price was at $11.68.

Wolfe Research initiated coverage on Ameriprise Financial Inc AMP with an Outperform rating. The price target for Ameriprise Financial is set to $328.00. In the second quarter, Ameriprise Financial showed an EPS of $5.27, compared to $2.64 from the year-ago quarter. The current stock performance of Ameriprise Financial shows a 52-week-high of $284.09 and a 52-week-low of $155.33. Moreover, at the end of the last trading period, the closing price was at $277.23.

With an Outperform rating, Bernstein initiated coverage on BeiGene Ltd BGNE. The price target seems to have been set at $431.00 for BeiGene. In the second quarter, BeiGene showed an EPS of $5.23, compared to $4.31 from the year-ago quarter. At the moment, the stock has a 52-week-high of $426.56 and a 52-week-low of $219.20. BeiGene closed at $363.53 at the end of the last trading period.

Bernstein initiated coverage on Zai Lab Ltd ZLAB with a Market Perform rating. NoneThe stock has a 52-week-high of $193.54 and a 52-week-low of $80.46. At the end of the last trading period, Zai Lab closed at $101.70.

William Blair initiated coverage on Ginkgo Bioworks Holdings Inc DNA with an Outperform rating. The current stock performance of Ginkgo Bioworks Holdings shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $9.47.

Roth Capital initiated coverage on Rush Street Interactive Inc RSI with a Buy rating. The price target for Rush Street Interactive is set to $24.00. In the second quarter, Rush Street Interactive earned $0.04. The current stock performance of Rush Street Interactive shows a 52-week-high of $26.55 and a 52-week-low of $9.47. Moreover, at the end of the last trading period, the closing price was at $20.32.

With an Outperform rating, RBC Capital initiated coverage on aTyr Pharma Inc LIFE. The price target seems to have been set at $22.00 for aTyr Pharma. In the second quarter, aTyr Pharma showed an EPS of $0.64, compared to $0.69 from the year-ago quarter. The stock has a 52-week-high of $13.10 and a 52-week-low of $2.93. At the end of the last trading period, aTyr Pharma closed at $9.42.

With a Neutral rating, Goldman Sachs initiated coverage on Hippo Holdings Inc HIPO. The price target seems to have been set at $5.40 for Hippo Holdings. Interestingly, in the second quarter, Hippo Holdings's EPS was $0.46. At the moment, the stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Hippo Holdings closed at $4.36 at the end of the last trading period.

With an Outperform rating, Credit Suisse initiated coverage on FREYR Battery FREY. The price target seems to have been set at $13.00 for FREYR Battery. Interestingly, in the second quarter, FREYR Battery's EPS was $0.04. The stock has a 52-week-high of $13.80 and a 52-week-low of $7.71. At the end of the last trading period, FREYR Battery closed at $9.70.

Credit Suisse initiated coverage on eFFECTOR Therapeutics Inc EFTR with an Outperform rating. The price target for eFFECTOR Therapeutics is set to $20.00. The current stock performance of eFFECTOR Therapeutics shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $10.35.

With a Buy rating, China Renaissance initiated coverage on Zhihu Inc ZH. The price target seems to have been set at $13.00 for Zhihu. In the second quarter, Zhihu earned $0.08. At the moment, the stock has a 52-week-high of $13.85 and a 52-week-low of $6.81. Zhihu closed at $9.75 at the end of the last trading period.

See all analyst ratings initiations.